You searched for metabolic diseases - Page 17 of 64

Best in Biotech 18 Apr 2024

5 RNA editing companies you should know about

…rare and common diseases. It is currently working on advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well…

April 18, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 10 Aug 2022

GentiBio and Bristol Myers Squibb to develop engineered Treg therapies for inflammatory bowel diseases

…with inflammatory bowel diseases (IBD). The collaboration brings together GentiBio’s engineered Treg platform for generating scalable, stable, highly-selective, and durable Tregs with Bristol Myers Squibb’s capacity in cell therapies and…

August 10, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 12 Jun 2023

Beacon Therapeutics launches with $120M to develop gene therapies for retinal diseases

Beacon Therapeutics Holdings Limited has been launched to develop gene therapies to treat a range of rare and prevalent retinal diseases that result in blindness. Syncona Limited, with additional investors…

June 12, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 3 Dec 2015

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

…immunotherapy. In some autoimmune diseases like Lupus, Crohn’s disease or rheumatoid arthritis, the cytokines that normally activate our immune system are overproduced. This overproduction can lead the immune system to…

December 3, 2015 - 4 minutesmins - By Joachim Eeckhout

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…leading T cell receptor (TCR) biotech company. With proprietary TCR technology, the company develops novel first-in-class biological therapies to treat a wide range of diseases including cancer, autoimmune diseases, and…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 22 Dec 2015

Serious Genetic Diseases have a New CRISPR Dream Duo Venture worth in Excess of €275M

…the Swiss biotech will keep a 50% ownership in the high-risk, high-reward areas of blood disorders, blindness, and congenital heart diseases. However, it will also retain full access to target…

December 22, 2015 - 2 minutesmins - By Dani Bancroft

Best in Biotech 25 Feb 2025

Seven biotech spinouts to watch out for in 2025

…means to turn research into products of commercial value, the biotech industry has witnessed quite a few spinouts develop from research projects over the years. From treating neurodegenerative diseases and…

February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter

Startup Scout 16 Mar 2018

This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases

…neurodegenerative conditions from Alzheimer’s and Parkinson’s to traumatic brain injury. The anitbodies identify molecules involved in neurodegenerative diseases such as amyloid beta and α-synuclein, which could help diagnose diseases before…

March 16, 2018 - 2 minutesmins - By Alexander Burik

Opinion 18 Dec 2023

What to expect from biotech clinical trials in the coming year

…diseases will continue to attract clinical research in 2024, continuing a long-term trend, according to Calliditas’ Aguiar-Lucander, including genetic and pediatric diseases such as Duchenne muscular dystrophy, Alport syndrome and…

December 18, 2023 - 11 minutesmins - By External Contributor

Best in Biotech 12 Nov 2024

Six exosome therapy companies driving development in the field

…diseases, such as cancer, neurological, and inflammatory diseases, several exosome therapy companies have come to the fore in recent times, with many just beginning to advance their candidates through the…

November 12, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 8 Feb 2021

How Next-Generation Gene Therapy Tackles Complex Diseases

Gene therapy has traditionally been applied to well-understood diseases where a single genetic mutation was to blame. A new generation of technology is expanding the potential of gene therapy to…

February 8, 2021 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Mar 2016

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Evotec (Germany) has launched a spin-off, Topas Therapeutics, to create nanoparticle-based therapeutics to treat immunological disorders. After starting a collaboration for microbiome-related diseases and entering the immuno-oncology field, Evotec is…

March 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

5 RNA editing companies you should know about

GentiBio and Bristol Myers Squibb to develop engineered Treg therapies for inflammatory bowel diseases

Beacon Therapeutics launches with $120M to develop gene therapies for retinal diseases

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Serious Genetic Diseases have a New CRISPR Dream Duo Venture worth in Excess of €275M

Seven biotech spinouts to watch out for in 2025

This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases

What to expect from biotech clinical trials in the coming year

Six exosome therapy companies driving development in the field

How Next-Generation Gene Therapy Tackles Complex Diseases

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!